Major cardiovascular events in patients with Coronavirus Disease 2019: Experience of a cardiovascular department of Northern Italy
- PMID: 33260043
- PMCID: PMC7647441
- DOI: 10.1016/j.thromres.2020.10.038
Major cardiovascular events in patients with Coronavirus Disease 2019: Experience of a cardiovascular department of Northern Italy
Abstract
- •
We report a translational experience of a cardiovascular department facing MACE in COVID-19 patients.
- •
Acute arterial events are the real emergency into this COVID-19 pandemic.
- •
COVID-19 infection may trigger a hypercoagulable status leading to MACE and high mortality rate.
- •
In this COVID-19 outbreak, the adjunct of heparin provides better survival chance independently of the infection-related drug treatment.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
Comment on
-
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.J Thromb Haemost. 2020 May;18(5):1094-1099. doi: 10.1111/jth.14817. Epub 2020 Apr 27. J Thromb Haemost. 2020. PMID: 32220112 Free PMC article.
Similar articles
-
Unpredictable Fall of Severe Emergent Cardiovascular Diseases Hospital Admissions During the COVID-19 Pandemic: Experience of a Single Large Center in Northern Italy.J Am Heart Assoc. 2020 Jul 7;9(13):e017122. doi: 10.1161/JAHA.120.017122. Epub 2020 May 22. J Am Heart Assoc. 2020. PMID: 32441548 Free PMC article.
-
Critical Organizational Issues for Cardiologists in the COVID-19 Outbreak: A Frontline Experience From Milan, Italy.Circulation. 2020 May 19;141(20):1597-1599. doi: 10.1161/CIRCULATIONAHA.120.047070. Epub 2020 Mar 24. Circulation. 2020. PMID: 32207994 No abstract available.
-
Effects of the COVID-19 Outbreak in Northern Italy: Perspectives from the Bergamo Neurosurgery Department.World Neurosurg. 2020 May;137:465-468.e1. doi: 10.1016/j.wneu.2020.03.179. Epub 2020 Apr 2. World Neurosurg. 2020. PMID: 32247797 Free PMC article. No abstract available.
-
Management of acute cardiovascular events in patients with COVID-19.Rev Cardiovasc Med. 2020 Dec 30;21(4):577-581. doi: 10.31083/j.rcm.2020.04.140. Rev Cardiovasc Med. 2020. PMID: 33388002 Review.
-
Cardiovascular Disease and SARS-CoV-2: the Role of Host Immune Response Versus Direct Viral Injury.Int J Mol Sci. 2020 Oct 30;21(21):8141. doi: 10.3390/ijms21218141. Int J Mol Sci. 2020. PMID: 33143371 Free PMC article. Review.
Cited by
-
Regional Survey in Lombardy, Northern Italy, on Vascular Surgery Intervention Outcomes During The COVID-19 Pandemic.Eur J Vasc Endovasc Surg. 2021 Apr;61(4):688-697. doi: 10.1016/j.ejvs.2021.01.037. Epub 2021 Mar 13. Eur J Vasc Endovasc Surg. 2021. PMID: 33722483 Free PMC article.
-
COVID-19 in thrombosis research: An editorial perspective.Thromb Res. 2021 May;201:147-150. doi: 10.1016/j.thromres.2021.03.011. Epub 2021 Mar 24. Thromb Res. 2021. PMID: 33798826 Free PMC article. No abstract available.
-
Marine natural products and human immunity: novel biomedical resources for anti-infection of SARS-CoV-2 and related cardiovascular disease.Nat Prod Bioprospect. 2024 Jan 29;14(1):12. doi: 10.1007/s13659-024-00432-4. Nat Prod Bioprospect. 2024. PMID: 38282092 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
